We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.35
Bid: 4.00
Ask: 4.70
Change: -0.15 (-3.33%)
Spread: 0.70 (17.50%)
Open: 4.35
High: 4.35
Low: 4.35
Prev. Close: 4.50
TAVI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re support to reject possible offer by TEAM

19 Apr 2021 09:59

RNS Number : 8798V
Tavistock Investments PLC
19 April 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

 

TEAM PLC HAS NOT ANNOUNCED A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY OFFER MIGHT BE MADE.

 

 

Tavistock Investments Plc

 

("Tavistock" or the "Company")

 

 Update re statements of intent from shareholders to reject any possible offer by TEAM plc

 

19 April 2021

 

The Board of Tavistock announces that it has received further letters from Paul Simpson and Denise Simpson stating their intention to reject the possible all share offer by TEAM plc ("TEAM") for the issued and to be issued share capital of Tavistock (the "Possible Offer").

 

These letters of intent (which are non-binding) represent, in aggregate, 1.00% of the Company's issued share capital and when taken with the previous letters of intent (as announced on 14 April 2021, 15 April 2021 and 16 April 2021 and set out in the table below) represent 35.10% of the Company's issued share capital. As also announced on 14 April 2021, the Board of Tavistock, who beneficially own, in aggregate, 97,337,016 Tavistock Shares, representing 16.01% of the Company's issued share capital, would also not be minded to recommend or accept any offer from TEAM were one to be made at the level of the Possible Offer. Accordingly, taking the Board of Tavistock's holdings together with the shares in respect of which the Company has received indications of intent to date, this represents 51.12% of the Company's issued share capital that would not accept an offer were one to be made at the level of the Possible Offer.

 

Since announcing the Possible Offer on 23 March 2021, TEAM has, up until 16 April 2021 (being the latest date prior to the publication of this announcement), announced that it has received non-binding letters of intent and an irrevocable undertaking in support of the Possible Offer from shareholders representing in aggregate, 15.03% of the Company's issued share capital.

 

Further details of the Tavistock letters of intent are set out below.

 

The Board of Tavistock remains of the view that the approach made by TEAM is without merit for the reasons previously stated, namely:

 

1) the Possible Offer significantly undervalues Tavistock's business;

 

2) the Board of Tavistock does not believe there to be any commercial logic to justify a combination of the two businesses; and

 

3) the Board of Tavistock does not consider that a paper-only offer, particularly one made using illiquid shares, is in the interests of the Company's shareholders.

 

Tavistock released a year-end trading update on 8 April 2021 noting that the Company has achieved a strong close to the financial year ended on 31 March 2021.

 

The Tavistock letters of intent confirm that the relevant shareholders are not in favour of the Possible Offer, details of which were announced by TEAM on 23 March 2021, and they intend to reject any potential offer to be made by TEAM. The letters go on to state that the relevant shareholders continue to support Tavistock's management team and its current strategy.

 

The table below sets out details of the Tavistock letters of intent that have been received from shareholders to date:

 

Tavistock shareholder

Number of Tavistock Shares covered by letter of intent

Percentage of Tavistock Shares covered by letter of intent

Andrew Staley

55,953,204

9.21

Hamon Capital Limited

30,000,000

4.94

Kevin Mee

27,475,963

4.52

Paul Millott

26,902,417

4.43

Malcolm Harper

13,200,000

2.17

Quay Limited

10,982,000

1.81

Ben Raven*

8,845,458

1.46

Neil Thomas

7,742,338

1.27

Jeremy Allard

7,120,735

1.17

Paul Simpson

4,788,793

0.79

James King

4,233,024

0.70

Paul Winfield

3,936,556

0.65

Jamie Raven*

2,624,876

0.43

Nicholas Cooling

1,875,000

0.31

Christopher Halford

1,457,981

0.24

Denise Simpson

1,272,454

0.21

Andrew Ross

985,083

0.16

Mrs A.J.Lewis

769,231

0.13

Estate of Alan Raven (deceased)

628,570

0.10

Clermont Limited

491,000

0.08

Andrew Fouracres

312,366

0.05

Gregor Preston

284,190

0.05

Kathryn McKimmie

330,000

0.05

John McKimmie

240,000

0.04

Mark Evans

250,000

0.04

Mark Wilson

250,000

0.04

Steven McGregor

264,400

0.04

Natalie Theobold

133,333

0.02

TOTAL

213,348,972

35.10

 

* Ben Raven and Jamie Raven are deemed to be acting in concert with the Directors of Tavistock

 

Enquiries:

 

Tavistock Investments Plc

Oliver Cooke

Brian Raven

 

Tel: 01753 867000

Allenby Capital Limited

(Financial Adviser, Nominated Adviser and Broker to Tavistock)

Corporate Finance:

Nick Naylor, David Worlidge, Nick Athanas, Liz Kirchner

Sales and Corporate Broking:

Tony Quirke

 

Tel: 020 3328 5656

Powerscourt (PR adviser to Tavistock)

Gilly Lock

Chloe Retief

Tel: 07711 380 007

020 7250 1446

 

 

Disclosure requirements of the Takeover Code

 

Under Rule 8.3(b) of the Takeover Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

 

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

 

Details of the offeree and offeror companies in respect of whose relevant securities Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk , including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Takeover Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make a Dealing Disclosure.

 

 Additional information

 

Allenby Capital Limited ("Allenby Capital"), is authorised and regulated by the Financial Conduct Authority in the United Kingdom. Allenby Capital is acting as financial adviser exclusively for Tavistock and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters set out in this announcement and will not be responsible to anyone other than Tavistock for providing the protections afforded to clients of Allenby Capital or its affiliates, or for providing advice in relation to the contents of this announcement or any other matter referred to herein.

 

Publication on a website

 

This announcement and the documents required to be published pursuant to Rule 26 of the Code will be available, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, on Tavistock's website at https://tavistockinvestments.com/ promptly and in any event by no later than 12 noon on the Business Day following the date of this announcement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OFDILMPTMTABMRB
Date   Source Headline
8th Jan 20247:00 amRNSDirector/PDMR Shareholding
4th Jan 20249:33 amRNSDirector/PDMR Shareholding
19th Dec 20237:00 amRNSInterim Results
1st Nov 202312:25 pmRNSResult of AGM
18th Oct 20234:58 pmRNSNotice of AGM
5th Oct 20237:00 amRNSTrading update and interim dividend declaration
20th Sep 20237:00 amRNSFinal Results for Year Ended 31 March 2023
28th Apr 20235:00 pmRNSTotal Voting Rights
11th Apr 20237:00 amRNSAcquisition of Precise Protect Limited
1st Mar 20237:00 amRNSTotal Voting Rights
16th Feb 20231:45 pmRNSExercise of Options and Total Voting Rights
10th Feb 20237:00 amRNSChange of Auditor
26th Jan 20237:00 amRNSDirector appointment
20th Dec 20227:00 amRNSInterim Results
1st Dec 20227:49 amRNSSale of LEBC Hummingbird Limited
30th Nov 20225:00 pmRNSTotal Voting Rights
22nd Nov 202212:30 pmRNSBuyback shares cancelled
18th Nov 20229:30 amRNSTransaction in Own Shares
4th Nov 202211:30 amRNSExercise of Options and Total Voting Rights
31st Oct 202212:00 pmRNSResult of AGM
6th Oct 20227:00 amRNSNotice of AGM
30th Sep 20225:00 pmRNSTotal Voting Rights
28th Sep 20227:00 amRNSPosting of Annual Report and Accounts
26th Sep 20227:00 amRNSFinal Results for Year Ended 31 March 2022
2nd Sep 202212:49 pmRNSExercise of Options and Total Voting Rights
31st Aug 20225:00 pmRNSTotal Voting Rights
24th Aug 20222:14 pmRNSBuyback shares cancelled
17th Aug 202210:41 amRNSTransaction in Own Shares
16th Aug 202210:14 amRNSDirector/PDMR Shareholding
26th Jul 202211:50 amRNSDirector/PDMR Shareholding
26th Jul 202210:33 amRNSDirector/PDMR Shareholding
12th Jul 20223:42 pmRNSHolding(s) in Company
12th Jul 20221:10 pmRNSHolding(s) in Company
4th Jul 202211:56 amRNSDirector/PDMR Shareholding
30th Jun 20226:29 pmRNSTotal Voting Rights
30th Jun 20222:20 pmRNSDirector/PDMR Shareholding
29th Jun 20222:22 pmRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSTrading update and interim dividend declaration
23rd Jun 20222:04 pmRNSExercise of Options and Total Voting Rights
23rd May 20227:00 amRNSAcquisition of LEBC Hummingbird Limited
10th May 20227:00 amRNSDirector/PDMR Shareholding
3rd May 20227:00 amRNSCompletion of purchase of minority holding in LEBC
31st Mar 20225:00 pmRNSTotal Voting Rights
21st Mar 20227:00 amRNSTotal Voting Rights & AIM Rule 17
17th Mar 20227:00 amRNSHolding(s) in Company
28th Feb 202211:06 amRNSSecond Price Monitoring Extn
28th Feb 202211:00 amRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Feb 202211:06 amRNSSecond Price Monitoring Extn
11th Feb 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.